Skip to content
Monday, May 23, 2022
HealthCare Africa Magazine

Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine

Africa Health & Wellness Expo ad
  • Home
  • TOPICS
    • INVESTMENTS & FUNDING
    • MERGERS & ACQUISITIONS
    • DISEASES UPDATES
    • HEALTHCARE DELIVERY
    • PHARMA MANUFACTURING
    • PEOPLE NEWS
    • CORONAVIRUS NEWS
    • REGULATORY & POLICY
  • THE MAGAZINE
    • About HealthCare Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • VIDEOS
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Sun Pharma to launch Brillo, a first in class oral lipid lowering drug
  • Globus Medical announces first surgeries using Excelsius3D
  • Humana, private equity firm launch 2nd primary care joint venture for Medicare patients
  • Covax wants urgent action to close vaccine equity gap
  • Health-tech Zuri Health secures US$1.3M in pre-seed round to expand operations across Africa
  • Bayer to end CAR T-cell therapies collaboration with Atara Biotherapeutics
  • WHO validates CONVIDECIA as 11th vaccine for COVID-19
  • India’s drug regulator approves Boehringer Ingelheim’s cardiac treatment
  • CCI approves Covidshield Technologies, Biocon Biologics merger
  • Aster DM flies higher with Skye Air drone partnership
You are here
  • Home
  • AbbVie

Tag: AbbVie

AbbVie to donate all Russia profits to humanitarian aid

20 April 202220 April 2022

UKRAINE – AbbVie has announced that all profits from its essential medicines sales in Russia will be donated to direct humanitarian relief efforts in Ukraine. AbbVie, along with Novartis and…

Read More

AbbVie’s Rinvoq debuts into gastroenterology space with FDA approval to include ulcerative colitis

18 March 202218 March 2022

USA – AbbVie has announced that the FDA has expanded Rinvoq (upadacitinib) approval to include the treatment of adults with moderate-to-severely active ulcerative colitis (UC) who have had insufficient response…

Read More

AbbVie and Richter expand partnership to develop neuropsychiatric diseases therapies

14 March 202214 March 2022

USA – US pharma major AbbVie has again linked up with Hungary’s largest drugmaker Gedeon Richter in research, development, and marketing of new dopamine receptor modulators for the treatment of…

Read More

AbbVie makes neuro drug connection with US$1 billion Syndesi Therapeutics acquisition

2 March 20222 March 2022

USA – AbbVie has expanded its neuropsychiatric and neurodegenerative portfolio with the US$1 billion acquisition of Belgium-based Syndesi Therapeutics. AbbVie will make an upfront payment of US$130 million to Syndesi…

Read More

Private Equity firms mull co-bidding for Novartis generics arm

3 February 20223 February 2022

SWITZERLAND – Two private equity giants are discussing launching a joint bid for Novartis’ generics unit, Bloomberg has reported. Novartis announced last year that it was conducting a strategic review…

Read More

Roche looks to compete against Regeneron’s blockbuster with its newly approved vision drug

31 January 202231 January 2022

SWITZERLAND – Roche announced that it has received FDA approval for the first-ever bispecific antibody treatment for two common causes of vision loss, paving the way for a battle with…

Read More

Eli Lilly to invest US$1B in manufacturing facility in North Carolina

30 January 20221 February 2022

USA – Eli Lilly and Company has announced that it will invest more than US$1 billion in a new manufacturing facility in North Carolina. Eli Lilly’s new facility in Concord,…

Read More

AbbVie, Pfizer’s JAK inhibitors get FDA clearance to treat atopic dermatitis

17 January 202221 January 2022

USA – The FDA has approved two once-daily, oral JAK inhibitors on for patients with moderate-to-severe atopic dermatitis whose disease is not well controlled with other systemic medications, including biologics,…

Read More

Sanofi in groundbreaking deal with ABL Bio to develop Parkinson’s disease drug

13 January 202213 January 2022

FRANCE – ABL Biotechnologies, a South Korean biotechnology firm, has signed a global licensing and exclusive collaboration agreement with Sanofi to develop and commercialize a new Parkinson’s disease therapy candidate.…

Read More

USFDA approves Sun Pharma’s generic Amphotericin B Liposome for injection

16 December 202116 December 2021

INDIA – Sun Pharmaceuticals Industries announced that one of its wholly-owned subsidiaries received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA)…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

Africa Health & Wellness Expo ad

Popular Posts Recent Posts

AAR Healthcare unveils new ultra-modern 140-bed capacity hospital

Ghanaian startup Yemaachi secures US$3M seed funding to advance cancer research

Lilly announces the Institute for Genetic Medicine and US$700 million investment

FDA OK’s Quantum’s Epione robot for liver cancer

Africa’s journey to healthcare independence, as fueled by effects of the ongoing pandemic

Sun Pharma to launch Brillo, a first in class oral lipid lowering drug

Globus Medical announces first surgeries using Excelsius3D

Humana, private equity firm launch 2nd primary care joint venture for Medicare patients

Covax wants urgent action to close vaccine equity gap

Health-tech Zuri Health secures US$1.3M in pre-seed round to expand operations across Africa

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Biogen Cancer China COVAX Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS India Investments & Funding Japan Johnson & Johnson Kenya Malaria Manufacturing Merck Mergers & Acquisitions Moderna MOH Kenya Nigeria Novartis Pfizer Pharmaceuticals Roche Sanofi Science & Technology South Africa Switzerland Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Africa MagazineFollow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCare Africa Magazine
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

About 1 billion people globally denied access to assistive products: Report
https://t.co/XdBGynFqHM #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment @WHO @UNICEF

Reply on Twitter 1527549390788902913Retweet on Twitter 15275493907889029131Like on Twitter 15275493907889029131Twitter 1527549390788902913
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

#Aenova Group invests US$11 mln to expand production of highly potent drugs in Germany
https://t.co/cRRWxBANAr #healthtech #innovation #healthcaredelivery #science #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1527546192435064832Retweet on Twitter 1527546192435064832Like on Twitter 1527546192435064832Twitter 1527546192435064832
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

Pollution caused 1 in 6 deaths globally for five years, study says
https://t.co/Wt2uRe1DHA #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #airpollution

Reply on Twitter 1527544485231607808Retweet on Twitter 1527544485231607808Like on Twitter 1527544485231607808Twitter 1527544485231607808
Retweet on TwitterHealthCare Africa Magazine Retweeted
OliveMugendaProf. Olive Mugenda Ph.D MGH@OliveMugenda·
May 18, 2022

The Cath-Lab at KUTRRH is now ready for commissioning. Cath-Lab is a specialised lab that deals with diagnosing blockages within the heart, unblocking as well as performing other interventions like cardiac pacemaker placements.
A great milestone for KUTRRH, MoH and Kenyans.

4
Reply on Twitter 1526921388057051137Retweet on Twitter 152692138805705113727Like on Twitter 1526921388057051137119Twitter 1526921388057051137
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Health and wellness startup @FlexifyMe raises US$300K in seed round
https://t.co/vyCRnHxiil #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #wellness #startup

Reply on Twitter 1526125167860146177Retweet on Twitter 1526125167860146177Like on Twitter 1526125167860146177Twitter 1526125167860146177
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa magazine

Food Business Africa magazine

Food Safety Africa magazine

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.